APA (7th ed.) Citation

X, L., Q, Y., W, W., T, L., & J, H. (2019). VE-822 mediated inhibition of ATR signaling sensitizes chondrosarcoma to cisplatin via reversion of the DNA damage response. Dove Medical Press.

Chicago Style (17th ed.) Citation

X, Liang, Yang Q, Wang W, Liu T, and Hu J. VE-822 Mediated Inhibition of ATR Signaling Sensitizes Chondrosarcoma to Cisplatin via Reversion of the DNA Damage Response. Dove Medical Press, 2019.

MLA (8th ed.) Citation

X, Liang, et al. VE-822 Mediated Inhibition of ATR Signaling Sensitizes Chondrosarcoma to Cisplatin via Reversion of the DNA Damage Response. Dove Medical Press, 2019.